Track topics on Twitter Track topics that are important to you
Biopharmaceutical company Bristol-Myers Squibb (BMS) has partnered with drug development accelerator BioMotiv to form and fund new companies for the...Read More... The post BMS partners with BioMotiv ...
Bristol-Myers Squibb Co. agreed to become a limited partner in BioMotiv LLC. Together they will establish start-ups, which BMS might eventually buy.
TamRx, a cancer immunotherapy firm, was launched jointly by BioMotiv and Rutgers University on Thursday to advance its experi -More-
Bristol-Myers Squibb has entered a limited partnership with BioMotiv, a drug development accelerator, to support research at -More-
CLEVELAND & NEW YORK–(BUSINESS WIRE)–BioMotiv, a mission-driven drug development accelerator that advances breakthrough discoveries from research institutions into therapeutics, and Br...
The pharmaceutical giant seeks to accelerate scientific discoveries into breakthrough therapies for patients living with severe diseases
BioMotiv, a mission-driven drug development accelerator that advances breakthrough discoveries from research institutions into therapeutics, and Bristol-Myers Squibb Company (NYSE: BMY) today announc...
BioMotiv is the mission-driven accelerator associated with The Harrington Project for Discovery & Development, a $340 million initiative for advancing medicine centered at Univers...
We have published hundreds of BioMotiv news stories on BioPortfolio along with dozens of BioMotiv Clinical Trials and PubMed Articles about BioMotiv for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioMotiv Companies in our database. You can also find out about relevant BioMotiv Drugs and Medications on this site too.
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...